Head and Neck NeoplasmPEGNCT04151030
Endoscopic Direct-PEG Placement in Patients Unable to Undergo Pull-PEG Procedure
A study testing PEG placement in people with Head and Neck Neoplasm and Gastrostomy, run by Kansas City Veteran Affairs Medical Center at 1 site in United States.
Trial summary
Placement of a feeding tube through a gastrostomy can be performed endoscopically or radiologically. While percutaneous endoscopic gastrostomy (PEG) tube placement is most frequently performed using a "pull" technique, this method may not feasible in patients with malignant, or tight benign, esophageal stenosis. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Head and Neck Neoplasm, Gastrostomy, Esophageal Stenosis and Obstruction
- What is being tested?
- PEG placement
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 45 participants
- Where
- 1 siteUnited States
- Study dates
- 28 Jun 2019to 1 Jul 2021
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Placement of PEG tube for dysphagia
- Inability of participant to undergo conventional Pull PEG (for any reason)
- Attempt at placement of a Push PEG
- Age > 18 years and able to consent
Who cannot join
- Successful placement of Pull PEG
- Ascites, pregnancy
Trial locations and contacts
1 site in 1 country.
United States1 site
Kansas City VA medical center
Kansas City, Missouri, 64128
About this study
Placement of a feeding tube through a gastrostomy can be performed endoscopically or radiologically. While percutaneous endoscopic gastrostomy (PEG) tube placement is most frequently performed using a "pull" technique, this method may not feasible in patients with malignant, or tight benign, esophageal stenosis. Further, the "pull" technique may drag tumor cells with the feeding tube and lead to implantation metastasis at the gastrostomy site. A clinical practice update by the American Gastroenterological Association has recommended that the pull-through PEG placement method should be avoided in all patients with oropharyngeal or esophageal cancer. It also recommends that the introducer/Push PEG method should be favored instead of the pull PEG. In such situations, an introducer-style, "Direct" gastrostomy tube can be placed endoscopically or radiologically. However, the published data comparing outcomes and safety of endoscopic "Direct" PEG (D-PEG) and interventional radiological PEG (IR-PEG) are very sparse.
The D-PEG is performed under endoscopic visualization of the gastric wall which facilitates greater control and allows safe selection of gastrostomy site. Further, the presence of an endoscope enables transillumination to confirm the absence of intervening abdominal viscera between the abdominal wall and the anterior wall of the stomach. These advantages are lacking with the IR-PEG. We hypothesize that D-PEG is safer than IR-PEG.
In this single center, non-randomized study, patients unable to undergo a conventional per-oral "Pull" PEG and needing a D-PEG will be prospectively enrolled. For the comparison arm, historical IR-PEG procedures at our center will be assessed. The technical success and rates of adverse events will be compared between the two arms. Approval from the Institutional review board has been obtained. Based on our experience, we estimate a sample size of 40 participants in each arm and anticipate completion of this pilot study by June 2021.
Read the detailed description
Introduction Percutaneous endoscopic gastrostomy (PEG) tube placement is a frequently performed procedure to provide enteral nutrition in patients with dysphagia. Two methods are used for placing a PEG tube via the mouth: The "Pull" method and the "Push" method(1). In the "Pull" technique, the feeding tube is pulled from the mouth, through the esophagus and stomach to the outside. In the introducer-style "Direct" technique, the feeding tube is pushed from the outside to inside the stomach. Both these techniques are considered safe, effective, and have their own advantages and disadvantages(2).
Limitations of Pull PEG technique The "Pull" PEG technique is challenging in patients with head and neck malignancies, obstructing esophageal cancers, and laryngeal malignancies. The severe stenosis often precludes the passage of the adult endoscope as well as the large internal bumper of the feeding tube which must be pulled through the stenotic upper gastrointestinal tract. Further, microorganisms and malignant cells from the oropharynx/ esophagus can be pulled by the feeding tube leading to peristomal infections as well as metastatic deposits at the site of the gastrostomy(3,4). A prospective evaluation of "Pull" PEGs placed in patients with oropharyngeal and esophageal tumors revealed metastatic deposits of malignant cells in 9.5% of patients, 16 weeks after the PEG(5). Retrospective assessment of PEG placement for oropharyngeal cancer demonstrated abdominal wall metastasis of 0.64%(6).
Direct PEG technique The endoscopic Direct PEG (D-PEG) uses the Russel introducer technique which obviates the passage of the gastrostomy tube through the oropharynx. Further, it can also be performed with an ultrathin endoscope which is easy to navigate through stenotic or malignant upper gastrointestinal tract obstructions. The D-PEG requires performance of gastropexy (attachment of gastric wall to the abdominal wall using sutures) with anchor-like T-fasteners for easy and safe placement of the PEG tube(2).
The D-PEG is performed under endoscopic visualization of the gastric wall which facilitates greater control and allows safe selection of gastrostomy site. It also obviates the need for ionizing radiation. Further, the endoscope enables transillumination to confirm the absence of intervening abdominal viscera between the abdominal wall and stomach. These advantages are lacking in IR-guided PEG which does not offer endoscopic visualization of the gastric lumen.
Currently, patients who fail a per-oral Pull PEG tube placement are typically referred for IR-guided PEG placement(3). Thus, patients who fail a "pull" PEG procedure, are referred to IR for a second invasive procedure. However, with the availability of the D-PEG, patients failing a "Pull" PEG can undergo a PEG placement during the index procedure.
Recommendations from GI societies A recently published clinical practice update has recommended that the pull-through PEG placement method should be avoided in all patients with oropharyngeal or esophageal cancer, to reduce the risk of implantation metastasis. Further, the authors recommend that the introducer/Push PEG method should be favored instead of the pull PEG(7,8).
Hypothesis We hypothesize that the D-PEG is safer than the IR-PEG in patients unable to undergo a per-oral Pull PEG.
Aims Primary Aim: Comparison of adverse events of D-PEG vs IR-PEG in patients unable to undergo a Pull PEG Secondary aims: Comparison of technical success and overall procedure duration between D-PEG and IR-PEG in patients unable to undergo a Pull PEG The data from this pilot study will be used to design a multi-center prospective randomized trial comparing outcomes and safety of D-PEG and IR-PEG. The subsequent trial is intended to be performed at different centers where these procedures are routinely performed, such as Virginia Commonwealth University, University of Utah, and Baylor College, TX.
Pilot data The investigators have received approval from the institutional review board. We have performed D-PEG procedure in 13 patients so far with technical success in 12 patients (92%). There have been no major adverse events including perforation, significant procedure-related bleeding, or procedure related death. One patient accidentally dislodged his tube which was replaced without endoscopic intervention (minor adverse event: 1).
Research design This will be a prospective study of participants undergoing D-PEG placement compared with patients who previously underwent IR-PEG placement.
Endoscopic/prospective arm The patients who fail the endoscopic pull PEG placement, or are not candidates for a Pull PEG, will undergo an D-PEG procedure at the time of the index endoscopy. During the pre-procedure consent process, participants will be offered IR-guided PEG placement as an alternative. This is the standard of care for patients who present to the endoscopy unit for PEG tube placement. All standard protocols including pre-procedure assessment, intra-procedure antibiotic use and post procedure protocols will be observed. In addition to the standard care which all patients receive, the technical success and adverse event rates will be recorded. Participants will receive a phone call within 1 week, and within 30 days of the procedure to assess for any post-procedure complications. These data will be recorded in the medical chart.
The study will be performed at Kansas City VA Medical Center, Kansas City, Missouri. The procedures will be performed by trained, board-certified gastroenterologists with extensive experience in placing PEG tubes.
Statistical Analysis/power analysis:
We will compare the technical success of D-PEG versus IR-PEG placement. Technical success is defined as the successful placement of the D PEG.
Primary outcome (adverse event rate):
We assume 15% complications (bleeding, infection, tube dislodgement, perforation) with IR-PEGs and 5% complications in D-PEGs. With 80% power to test a noninferiority margin of 5%, we intend to enroll 50 patients in the prospective arm done by endoscopists and 50 patients in the retrospective arm done by IR.
Secondary outcome (technical success) We assume a 95% technical success rate on IR guided push PEG placement. We also assume a 90% technical success rate on endoscopic push PEG placement. Using a non-inferior to margin of 20%, and an 80% power to test the hypothesis, we intend to enroll 50 patients in the prospective arm and 50 patients in the retrospective arm.
We will use Student's t-test compare means and chi-square test to compare the two arms. We will also use multi variate analysis and ANOVA for the analysis of all variables.
Recruitment of subjects
Patients with dysphagia requiring PEG placement will be recruited from the following sites:
Referred to the GI clinic for placement of a gastrostomy tube Referred by the Kansas City VA tumor board for placement of a gastrostomy tube (e.g. head and neck cancers and esophageal malignancies) Outpatient or Inpatient GI consults for gastrostomy tube placement Patient's meeting the inclusion and exclusion criteria listed above will then be assessed by the principal investigator and offered enrollment into the study.
- Being tested
- PEG placement
- Medical subject headings
- Head and Neck Neoplasms, Esophageal Stenosis, Bites and Stings
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
PEG placementProcedure or surgery
Push PEG placement
| Study group | Role | What they receive |
|---|---|---|
| Endoscopic-PEG | Experimental | The patients who are unable to undergo an endoscopic pull PEG placement, will undergo an Endoscopic "introducer style" Direct-PEG procedure at the time of the index endoscopy Receives: Procedure: PEG placement |
| IR-PEG | Active comparator | Patients who underwent PEG placement by interventional radiology (IR-PEG). Receives: Procedure: PEG placement |
What is being measured
The primary outcome is the main question the study is designed to answer.
Technical success of endoscopic vs radiographic Push-PEG placement in patients who are not candidates for a Pull-PEG placement
Successful placement of PEG
Measured: 30 days
Secondary outcomes (2)
Incidence of adverse events between endoscopic push PEG placement and IR guided push PEG placement
Tube dislodgement: Defined as the unanticipated removal of the feeding tube from the site of the gastrostomy Infection at PEG site/buried bumper syndrome: Localized infection requiring intervention including antibiotics/change of dressings/removal of PEG tube/replacement of PEG tube Bleeding requiring intervention: Any significant bleeding requiring endoscopic intervention or transfusion or hospitalization Perforation of any organ (excluding gastrostomy creation) Peritonitis Pain: Post-procedure pain requiring outpatient analgesics (not previously prescribed) Death from procedure
Measured: 30 days
Procedure duration between endoscopic push PEG placement and IR guided push PEG placement
Duration from timeout to completion; duration from trans-illumination to completion
Measured: At the time of procedure
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted5 Nov 2019
- Study start28 Jun 2019
- Primary completion1 Jul 2021
- Study completion1 Jul 2021
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Head and Neck NeoplasmStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Non-randomised
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 45 participants (actual)
Sponsor and investigators
- Lead sponsor
- Kansas City Veteran Affairs Medical Center
- Sponsor type
- US federal agency
- Responsible party
- Principal investigator, Divyanshoo Kohli, Kansas City Veteran Affairs Medical Center
- Investigators
- Divyanshoo Kohli, MD, Principal investigator, Kansas City VA Medical Center
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04151030
- Sponsor's protocol ID
- 01049
- Acronym
- PEG
- Status last verified
- Aug 2021
- First submitted
- 31 Oct 2019
- Last updated
- 1 Sep 2021
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Kohli DR, Smith C, Chaudhry O, Desai M, DePaolis D, Sharma P. Direct Percutaneous Endoscopic Gastrostomy Versus Radiological Gastrostomy in Patients Unable to Undergo Transoral Endoscopic Pull Gastrostomy. Dig Dis Sci. 2023 Mar;68(3):852-859. doi: 10.1007/s10620-022-07569-7. Epub 2022 Jun 16.
PubMed 35708794
Study at a glance
From the registry record, last updated by the sponsor on 1 Sep 2021. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Endoscopic Direct-PEG Placement in Patients Unable to Undergo Pull-PEG Procedure
- ClinicalTrials.gov ID
- NCT04151030
- Acronym / sponsor ID
- PEG / 01049
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 45 participants (actual)
- Lead sponsor
- Kansas City Veteran Affairs Medical CenterUS federal agency
- Study start
- 28 Jun 2019 (actual)
- Primary completion
- 1 Jul 2021 (actual)
- Study completion
- 1 Jul 2021 (actual)
- First posted
- 5 Nov 2019 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Placement of a feeding tube through a gastrostomy can be performed endoscopically or radiologically. While percutaneous endoscopic gastrostomy (PEG) tube placement is most frequently performed using a "pull" technique, this method may not feasible in patients with malignant, or tight benign, esophageal stenosis. Further, the "pull" technique may drag tumor cells with the feeding tube and lead to implantation metastasis at the gastrostomy site. A clinical practice update by the American Gastroenterological Association has recommended that the pull-through PEG placement method should be avoided in all patients with oropharyngeal or esophageal cancer. It also recommends that the introducer/Push PEG method should be favored instead of the pull PEG. In such situations, an introducer-style, "Direct" gastrostomy tube can be placed endoscopically or radiologically. However, the published data comparing outcomes and safety of endoscopic "Direct" PEG (D-PEG) and interventional radiological PEG (IR-PEG) are very sparse.
The D-PEG is performed under endoscopic visualization of the gastric wall which facilitates greater control and allows safe selection of gastrostomy site. Further, the presence of an endoscope enables transillumination to confirm the absence of intervening abdominal viscera between the abdominal wall and the anterior wall of the stomach. These advantages are lacking with the IR-PEG. We hypothesize that D-PEG is safer than IR-PEG.
In this single center, non-randomized study, patients unable to undergo a conventional per-oral "Pull" PEG and needing a D-PEG will be prospectively enrolled. For the comparison arm, historical IR-PEG procedures at our center will be assessed. The technical success and rates of adverse events will be compared between the two arms. Approval from the Institutional review board has been obtained. Based on our experience, we estimate a sample size of 40 participants in each arm and anticipate completion of this pilot study by June 2021.
Detailed description
Introduction Percutaneous endoscopic gastrostomy (PEG) tube placement is a frequently performed procedure to provide enteral nutrition in patients with dysphagia. Two methods are used for placing a PEG tube via the mouth: The "Pull" method and the "Push" method(1). In the "Pull" technique, the feeding tube is pulled from the mouth, through the esophagus and stomach to the outside. In the introducer-style "Direct" technique, the feeding tube is pushed from the outside to inside the stomach. Both these techniques are considered safe, effective, and have their own advantages and disadvantages(2).
Limitations of Pull PEG technique The "Pull" PEG technique is challenging in patients with head and neck malignancies, obstructing esophageal cancers, and laryngeal malignancies. The severe stenosis often precludes the passage of the adult endoscope as well as the large internal bumper of the feeding tube which must be pulled through the stenotic upper gastrointestinal tract. Further, microorganisms and malignant cells from the oropharynx/ esophagus can be pulled by the feeding tube leading to peristomal infections as well as metastatic deposits at the site of the gastrostomy(3,4). A prospective evaluation of "Pull" PEGs placed in patients with oropharyngeal and esophageal tumors revealed metastatic deposits of malignant cells in 9.5% of patients, 16 weeks after the PEG(5). Retrospective assessment of PEG placement for oropharyngeal cancer demonstrated abdominal wall metastasis of 0.64%(6).
Direct PEG technique The endoscopic Direct PEG (D-PEG) uses the Russel introducer technique which obviates the passage of the gastrostomy tube through the oropharynx. Further, it can also be performed with an ultrathin endoscope which is easy to navigate through stenotic or malignant upper gastrointestinal tract obstructions. The D-PEG requires performance of gastropexy (attachment of gastric wall to the abdominal wall using sutures) with anchor-like T-fasteners for easy and safe placement of the PEG tube(2).
The D-PEG is performed under endoscopic visualization of the gastric wall which facilitates greater control and allows safe selection of gastrostomy site. It also obviates the need for ionizing radiation. Further, the endoscope enables transillumination to confirm the absence of intervening abdominal viscera between the abdominal wall and stomach. These advantages are lacking in IR-guided PEG which does not offer endoscopic visualization of the gastric lumen.
Currently, patients who fail a per-oral Pull PEG tube placement are typically referred for IR-guided PEG placement(3). Thus, patients who fail a "pull" PEG procedure, are referred to IR for a second invasive procedure. However, with the availability of the D-PEG, patients failing a "Pull" PEG can undergo a PEG placement during the index procedure.
Recommendations from GI societies A recently published clinical practice update has recommended that the pull-through PEG placement method should be avoided in all patients with oropharyngeal or esophageal cancer, to reduce the risk of implantation metastasis. Further, the authors recommend that the introducer/Push PEG method should be favored instead of the pull PEG(7,8).
Hypothesis We hypothesize that the D-PEG is safer than the IR-PEG in patients unable to undergo a per-oral Pull PEG.
Aims Primary Aim: Comparison of adverse events of D-PEG vs IR-PEG in patients unable to undergo a Pull PEG Secondary aims: Comparison of technical success and overall procedure duration between D-PEG and IR-PEG in patients unable to undergo a Pull PEG The data from this pilot study will be used to design a multi-center prospective randomized trial comparing outcomes and safety of D-PEG and IR-PEG. The subsequent trial is intended to be performed at different centers where these procedures are routinely performed, such as Virginia Commonwealth University, University of Utah, and Baylor College, TX.
Pilot data The investigators have received approval from the institutional review board. We have performed D-PEG procedure in 13 patients so far with technical success in 12 patients (92%). There have been no major adverse events including perforation, significant procedure-related bleeding, or procedure related death. One patient accidentally dislodged his tube which was replaced without endoscopic intervention (minor adverse event: 1).
Research design This will be a prospective study of participants undergoing D-PEG placement compared with patients who previously underwent IR-PEG placement.
Endoscopic/prospective arm The patients who fail the endoscopic pull PEG placement, or are not candidates for a Pull PEG, will undergo an D-PEG procedure at the time of the index endoscopy. During the pre-procedure consent process, participants will be offered IR-guided PEG placement as an alternative. This is the standard of care for patients who present to the endoscopy unit for PEG tube placement. All standard protocols including pre-procedure assessment, intra-procedure antibiotic use and post procedure protocols will be observed. In addition to the standard care which all patients receive, the technical success and adverse event rates will be recorded. Participants will receive a phone call within 1 week, and within 30 days of the procedure to assess for any post-procedure complications. These data will be recorded in the medical chart.
The study will be performed at Kansas City VA Medical Center, Kansas City, Missouri. The procedures will be performed by trained, board-certified gastroenterologists with extensive experience in placing PEG tubes.
Statistical Analysis/power analysis:
We will compare the technical success of D-PEG versus IR-PEG placement. Technical success is defined as the successful placement of the D PEG.
Primary outcome (adverse event rate):
We assume 15% complications (bleeding, infection, tube dislodgement, perforation) with IR-PEGs and 5% complications in D-PEGs. With 80% power to test a noninferiority margin of 5%, we intend to enroll 50 patients in the prospective arm done by endoscopists and 50 patients in the retrospective arm done by IR.
Secondary outcome (technical success) We assume a 95% technical success rate on IR guided push PEG placement. We also assume a 90% technical success rate on endoscopic push PEG placement. Using a non-inferior to margin of 20%, and an 80% power to test the hypothesis, we intend to enroll 50 patients in the prospective arm and 50 patients in the retrospective arm.
We will use Student's t-test compare means and chi-square test to compare the two arms. We will also use multi variate analysis and ANOVA for the analysis of all variables.
Recruitment of subjects
Patients with dysphagia requiring PEG placement will be recruited from the following sites:
Referred to the GI clinic for placement of a gastrostomy tube Referred by the Kansas City VA tumor board for placement of a gastrostomy tube (e.g. head and neck cancers and esophageal malignancies) Outpatient or Inpatient GI consults for gastrostomy tube placement Patient's meeting the inclusion and exclusion criteria listed above will then be assessed by the principal investigator and offered enrollment into the study.
Study design
- Primary purpose
- Treatment
- Allocation
- Non-randomised
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Endoscopic-PEG | Experimental | Procedure: PEG placementThe patients who are unable to undergo an endoscopic pull PEG placement, will undergo an Endoscopic "introducer style" Direct-PEG procedure at the time of the index endoscopy |
| IR-PEG | Active comparator | Procedure: PEG placementPatients who underwent PEG placement by interventional radiology (IR-PEG). |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- Placement of PEG tube for dysphagia
- Inability of participant to undergo conventional Pull PEG (for any reason)
- Attempt at placement of a Push PEG
- Age > 18 years and able to consent
Key exclusion criteria (2 listed)
- Successful placement of Pull PEG
- Ascites, pregnancy
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| PEG placementPush PEG placement | Procedure or surgery | Endoscopic-PEG, IR-PEG |
Primary outcome
Technical success of endoscopic vs radiographic Push-PEG placement in patients who are not candidates for a Pull-PEG placement
Time frame: 30 days
Successful placement of PEG
2 secondary outcomes
Incidence of adverse events between endoscopic push PEG placement and IR guided push PEG placement
Time frame: 30 days
Procedure duration between endoscopic push PEG placement and IR guided push PEG placement
Time frame: At the time of procedure
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 1 Sep 2021.
- Derived from this study: PubMed 35708794Kohli DR, Smith C, Chaudhry O, Desai M, DePaolis D, Sharma P. Direct Percutaneous Endoscopic Gastrostomy Versus Radiological Gastrostomy in Patients Unable to Undergo Transoral Endoscopic Pull Gastrostomy. Dig Dis Sci. 2023 Mar;68(3):852-859. doi: 10.1007/s10620-022-07569-7. Epub 2022 Jun 16.
- Individual participant dataSharing planned: No
Related trials for Head and Neck Neoplasm
Not yet recruitingPhase 1/2
177Lu-DOTA-EB-TATE in Adult Patients With Metastatic, Radioactive Iodine Non-Responsive Oncocytic (Hurthle-Cell) Thyroid Cancer
Thyroid Cancer
Active, not recruitingPhase 1/2
A Beta-only IL-2 ImmunoTherapY Study
Advanced Solid Tumor, Unresectable Solid Tumor
RecruitingPhase 1/2
Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate Cancer
Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma
RecruitingPhase 1
A Study of MGC030 in Participants With Advanced Solid Tumors
Urothelial Cancer, GastroEsophageal Cancer
Not yet recruitingObservational study
Serum Treg/Th17-Related Cytokines and Systemic Inflammatory Indices in Differentiated Thyroid Cancer
Differentiated Thyroid Cancer (DTC), Papillary Thyroid Carcinoma
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Divyanshoo Kohli, MD principal investigator
Kansas City VA Medical Center
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing PEG placement in people with Head and Neck Neoplasm and Gastrostomy, run by Kansas City Veteran Affairs Medical Center at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 1 Sep 2021. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Technical success of endoscopic vs radiographic Push-PEG placement in patients who are not candidates for a Pull-PEG placement (time frame: 30 days). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT04151030, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Sep 2021.